Efficacy of sublingual immunotherapy

JAMA

Volumn 310, Issue 6, 2013, Pages 644-

  Moed, Heleen ^a   Rod̈er, Esther ^a   Bindels, Patrick ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GRASS POLLEN VACCINE; PLACEBO;

ALLERGIC DISEASE; ALLERGIC RHINOCONJUNCTIVITIS; ASTHMA; DRUG EFFICACY; GRASS POLLEN; HOUSE DUST ALLERGY; HUMAN; LETTER; POLLEN ALLERGY; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SUBLINGUAL IMMUNOTHERAPY; ALLERGIC CONJUNCTIVITIS; DESENSITIZATION; METHODOLOGY; NOTE; PERENNIAL RHINITIS;

ASTHMA; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS; RHINITIS, ALLERGIC, PERENNIAL;

EID: 84881435892     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.7643     Document Type: Letter

References (3)

1. Lin SY, Erekosima N, Kim JM, et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA. 2013;309(12):1278-1288.
2. Röder E, Berger MY, Hop WC, Bernsen RM, de Groot H, Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol. 2007;119(4):892-898. (Pubitemid 46527818)
3. de Bot CM, Moed H, Berger MY, et al. Sublingual immunotherapy not effective in house dustmite-allergic children in primary care. Pediatr Allergy Immunol. 2012;23(2):150-158.